Richard D Shell

Contact Information

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)

Learn more about Richard D. Shell

Biography

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Academic and Clinical Areas

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Awards, Honors & Organizations

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

Research

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Contact Information

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)

Learn more about Richard D. Shell

Biography

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Academic and Clinical Areas

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Awards, Honors & Organizations

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

Research

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Contact Information

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)

Learn more about Richard D. Shell

Contact Information

• Call us at:
• (614) 722-4766
• Fax us at:
• (614) 722-4755
• PediatricsPulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)

Learn more about Richard D. Shell

Biography

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Biography

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Biography

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Richard Shell, MD, is a professor of pediatrics and section chief of Department of Pulmonary Medicine and Nationwide Children’s Hospital and The Ohio State University College of Medicine. He plays an active clinical and research role in the care of patients with neuromuscular disease. His other research interests include asthma, bronchopulmonary dysplasia and cystic fibrosis where he is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and assists in many clinical trials within his Department. He graduated from the Medical College of Ohio in Toledo, Ohio and completed his residency and fellowship at Nationwide Children’s Hospital and The Ohio State University. He has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. He has won multiple teaching awards and has been recognized by his patients because of his excellence in family centered care.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

Locations

Main Campus of Nationwide Children’s Hospital

Nationwide Children’s Hospital Toledo

Languages Spoken

English French

• Main Campus of Nationwide Children’s Hospital

• Nationwide Children’s Hospital Toledo

• English

• French

Academic and Clinical Areas

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Academic and Clinical Areas

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Academic and Clinical Areas

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Cystic Fibrosis

Co-Director

Pulmonary Medicine

Section Chief

Asthma Program

Physician Team

Jeune’s Syndrome

Physician Team

Neuromuscular Disorders

Physician Team

Pediatric Pulmonary Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

• Cystic Fibrosis
• Co-Director
• Pulmonary Medicine
• Section Chief
• Asthma Program
• Physician Team
• Jeune’s Syndrome
• Physician Team
• Neuromuscular Disorders
• Physician Team
• Pediatric Pulmonary Fellowship
• Faculty
• Primary Department
• Pediatrics
• Primary Section
• Pulmonary, Sleep Medicine and Cystic Fibrosis

Awards, Honors & Organizations

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

Awards, Honors & Organizations

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

Awards, Honors & Organizations

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015 Listed, Best Doctors in America

• Golden Stethoscope Award Recipient, Nationwide Children’s Hospital, 2015
• Listed, Best Doctors in America

Research

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

Research

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

Research

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

                  Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;  

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.

                


                  Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.

                


                  Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;  

                


                  Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;  

                


                  Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L'Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;  

                


                  Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;  

                


                  Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.

                


                  Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.

                


                  Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

View More Publications

• Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J. Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform. 2022 Jan 24;
• Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.
• Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G. EVALI versus MIS-C, one more overlapping diagnosis to consider. Pediatr Pulmonol. 2021 Sep; 56: 2918-2924.
• Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.
• Paul GR, Gushue C, Kotha K, Shell R. The respiratory impact of novel therapies for spinal muscular atrophy. Pediatr Pulmonol. 2021 Apr; 56: 721-728.
• Paul GR, Khayat RN, Kotha K, Nandi D, Cripe L, Shell R. A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings. Chest. 2021 Jan; 159: e19-e23.
• Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurol. 2020 Jun 15;
• Mull ES, Erdem G, Nicol K, Adler B, Shell R. Eosinophilic Pneumonia and Lymphadenopathy Associated With Vaping and Tetrahydrocannabinol Use. Pediatrics. 2020 Mar 26;
• Al-Zaidy SA, Kolb SJ, Lowes L, Alfano LN, Shell R, Church KR, Nagendran S, Sproule DM, Feltner DE, Wells C, Ogrinc F, Menier M, L’Italien J, Arnold WD, Kissel JT, Kaspar BK, Mendell JR. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. J Neuromuscul Dis. 2019 Jul 30;
• Lowes LP, Alfano LN, Arnold WD, Shell R, Prior TW, McColly M, Lehman KJ, Church K, Sproule DM, Nagendran S, Menier M, Feltner DE, Wells C, Kissel JT, Al-Zaidy S, Mendell J. Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatr Neurol. 2019 May 13;
• Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2019 Feb; 54: 179-185.
• Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S62-S71.
• Bartlett A, Kolb SJ, Kingsley A, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Coffey CS, Yankey JW, Cudkowicz ME, McGovern MM, McNeil DE, Arnold WD, Kissel JT, NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.. Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! Contemp Clin Trials Commun. 2018 Sep; 11: 113-119.

Education

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Education

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Education

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

Date of Appointment at Nationwide Children’s Hospital: 11/16/1999

Board Certifications

Pediatric Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/1999

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/1996

Internship

Nationwide Children’s Hospital

Date Completed: 06/30/1994

Medical School

Medical College of Ohio at Toledo

Date Completed: 06/04/1993

• Pediatric Pulmonary Medicine

Contact Information

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4766

Fax us at: (614) 722-4755

                    Pulmonary Medicine700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-4766
• Fax us at:
• (614) 722-4755
• Pulmonary Medicine700 Children’s DrColumbus, OH 43205 (map)